Topiramate’s effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial

BACKGROUND: Schizophrenia is a psychiatric disorder with a higher mortality than that of the general population. Most of the deaths are due to cardiovascular causes and are related to metabolic risks. This risk is due not only to antipsychotics but also to inherent factors of the disorder. Studies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandradasa, Miyuru, Champika, Layani, de Silva, Silumini, Kuruppuarachchi, K. A. L. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607510/
https://www.ncbi.nlm.nih.gov/pubmed/28931411
http://dx.doi.org/10.1186/s13063-017-2162-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607510/
https://www.ncbi.nlm.nih.gov/pubmed/28931411
http://dx.doi.org/10.1186/s13063-017-2162-6

Ejemplares similares